Table 3.
Confidence in diagnosis and therapeutic decision after initial imaging (efficacy population)
| Confidence |
||||||
|---|---|---|---|---|---|---|
| Initial imaging technique | All patientsxs | Very low | Low | Moderate | High | Very high |
| Gadoxetic acid-enhanced MRI* | 118 | 0 (0) | 0 (0) | 2 (1·7) | 36 (30·5) | 80 (67·8) |
| ECCM-MRI* | 112 | 0 (0) | 1 (0·9) | 15 (13·4) | 48 (42·9) | 48 (42·9) |
| CE-CT* | 112 | 0 (0) | 13 (11·6) | 26 (23·2) | 44 (39·3) | 29 (25·9) |
Values in parentheses are percentages. MRI, magnetic resonance imaging; ECCM, extracellular contrast medium; CE-CT, contrast-enhanced computed tomography.
*
Wilcoxon two-sample tests resulted in two-sided P < 0·001 for the comparisons of gadoxetic acid-enhanced MRI versus ECCM-MRI and CE-CT.